Translate Bio Announces First Quarter 2019 Financial Results and Provides Corporate Update

NEXT STORY
Checkpoint Therapeutics Reports First Quarter 2019 Financial Results and Recent Corporate Highlights
PREV STORY
BioCryst Completes Phase 1 Clinical Trial of Galidesivir
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Ascendis Pharma A/S Announces Preliminary Six-Month Data from Open-Label Extension of Phase 2 PaTH Forward Trial and Files IND Amendment to Initiate Phase 3 PaTHway Trial of TransCon™ PTH in Adult Hypoparathyroidism

author_avatar
NASDAQ Market News

Globus Medical Announces Corporate Alliance Partnership with the Society of Lateral Access Surgery

author_avatar
NASDAQ Market News

WISeKey renews strategic IoT patent for the digital authentication method of valuable goods on the Internet

author_avatar
NASDAQ Market News